Status:
UNKNOWN
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
Lead Sponsor:
University of Monastir
Conditions:
Acute Asthma
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Our study is a prospective double-blind randomized study performed in the Emergency Department (ED). The objective of our study was to demonstrate the additive effect of high and repeated doses of inh...
Detailed Description
Patients were included in a double-blind, randomized into one of two groups. The experimental group received a first nebulization of 5 mg of terbutaline (Bricanyl®, AstraZeneca : solution of 5mg/ 2 ml...
Eligibility Criteria
Inclusion
- acute asthma
- peak expiratory flow (PEF) rate less than 50% of predicted value
- one or more of the following features were present: accessory muscle activity, a heart rate greater than 110 beats/minute, a respiratory rate greater than 25 breaths/minute, a limited ability to speak
- written informed consent obtained
Exclusion
- temperature higher than 38°C
- history of cardiac, hepatic, renal, or other medical disease
- pregnant
Key Trial Info
Start Date :
May 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 20 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04016220
Start Date
May 20 2019
End Date
May 20 2020
Last Update
July 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Monastir
Monastir, Tunisia, 5000